Compare Lustrum:Nichi-Iko Pharmaceutical Co.,Ltd.:4541

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nichi-Iko Pharmaceutical Co.,Ltd. Go to web site 4541 Medicals 東証プライム March 1, 2000 1980.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Nichi-Iko Pharmaceutical Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nichi-Iko Pharmaceutical Co.,Ltd. Balance Sheet 2022年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Balance Sheet 2021年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Balance Sheet 2020年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Balance Sheet 2019年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Balance Sheet 2018年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Cash and Cash Equivalents
(Percent)
15,305down
(5.9%)down
29,142down
(8.0%)down
42,944up
(12.7%)down
42,093up
(13.7%)up
18,529
(6.7%)
Other Current AssetsHelp
(Percent)
140,086down
(53.8%)up
145,960up
(40.1%)up
121,764up
(36.2%)up
100,629down
(32.8%)down
109,749
(39.4%)
Tangible Fixed AssetsHelp
(Percent)
39,289down
(15.1%)down
68,943up
(19.0%)up
59,201up
(17.6%)down
55,710up
(18.2%)down
54,045
(19.4%)
Intangible Fixed AssetHelp
(Percent)
39,609down
(15.2%)down
56,957up
(15.7%)down
56,607up
(16.8%)up
46,721up
(15.2%)down
45,735
(16.4%)
Investments and OthersHelp
(Percent)
7,791down
(3.0%)down
16,909up
(4.7%)up
11,981down
(3.6%)down
18,793up
(6.1%)up
11,770
(4.2%)
Total AssetsHelp
(Percent)
260,559
(100%)
363,572
(100%)
336,819
(100%)
306,838
(100%)
278,364
(100%)
Total Current LiabilitiesHelp
(Percent)
170,063up
(65.3%)up
166,384up
(45.8%)up
133,947up
(39.8%)up
99,776down
(32.5%)down
105,197
(37.8%)
Total Long-term LiabilitiesHelp
(Percent)
77,102down
(29.6%)up
86,021down
(23.7%)down
87,045down
(25.8%)down
90,739up
(29.6%)down
85,625
(30.8%)
Shareholder's EquityHelp
(Percent)
13,394down
(5.1%)down
111,167down
(30.6%)down
115,827down
(34.4%)down
116,323up
(37.9%)up
87,542
(31.4%)
Total LiabilitiesHelp
(Percent)
260,559
(100%)
363,572
(100%)
336,819
(100%)
306,838
(100%)
278,364
(100%)

Nichi-Iko Pharmaceutical Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nichi-Iko Pharmaceutical Co.,Ltd. Profit and Loss Account 2022年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Profit and Loss Account 2021年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Profit and Loss Account 2020年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Profit and Loss Account 2019年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Profit and Loss Account 2018年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Amount of Sales
(Percent)
179,060
(100%)
188,218
(100%)
190,076
(100%)
166,592
(100%)
164,717
(100%)
Total Sales
(Percent)
179,060
(100%)
188,218
(100%)
190,076
(100%)
166,592
(100%)
164,717
(100%)
Cost of SalesHelp
(Percent)
175,094up
(97.8%)up
166,973up
(88.7%)up
152,756up
(80.4%)up
133,434up
(80.1%)up
123,914
(75.2%)
Other Costs and RevenueHelp 108,950up
(60.8%)up
25,426down
(13.5%)down
32,187up
(16.9%)up
26,294down
(15.8%)down
32,733
(19.9%)
Total CostsHelp 284,044 192,399 184,943 159,728 156,647
Net RevenueHelp 3,966down
(2.2%)down
21,245down
(11.3%)down
37,320up
(19.6%)down
33,158down
(19.9%)down
40,803
(24.8%)
Earnings Before TaxHelp -107,842down
(-60.2%)down
1,068down
(0.6%)down
7,396down
(3.9%)down
8,903down
(5.3%)down
9,067
(5.5%)
Net IncomeHelp -104,984down
(-58.6%)down
-4,181down
(-2.2%)down
5,133down
(2.7%)down
6,864down
(4.1%)down
8,070
(4.9%)
当期純利益 -104,984 -4,181 5,133 6,864 8,070

Nichi-Iko Pharmaceutical Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nichi-Iko Pharmaceutical Co.,Ltd. Cash Flow Statement 2022年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Cash Flow Statement 2021年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Cash Flow Statement 2020年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Cash Flow Statement 2019年3月期 Nichi-Iko Pharmaceutical Co.,Ltd. Cash Flow Statement 2018年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019 March 31, 2018
Operating Cash Flow(OFC)Help
(Percent)
-24,248down
(-72.2%)down
5,007down
(16.9%)down
18,449down
(94.8%)up
23,810up
(49.0%)down
18,924
(85.5%)
Investing Cash Flow(ICF)Help
(Percent)
-9,315up
(-27.8%)up
-29,334down
(-98.9%)down
-18,228up
(-93.7%)down
-24,983down
(-51.4%)up
-15,896
(-71.8%)
Financing Cash FlowHelp
(Percent)
19,677up
(58.6%)up
10,867up
(36.6%)up
1,002down
(5.2%)down
24,803up
(51.0%)up
3,206
(14.5%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
49up
(0.1%)up
-341up
(-1.1%)up
-373down
(-1.9%)down
-66up
(-0.1%)up
-163
(-0.7%)
Net Increase and Decrease in Cash and Cash Equivalentsn -13,837down
(-41.2%)up
-13,801down
(-46.5%)down
850down
(4.4%)down
23,564up
(48.5%)up
6,071
(27.4%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nichi-Iko Pharmaceutical Co.,Ltd.

Company where related level is highHelp

TORII PHARMACEUTICAL CO.,LTD.
Daito Pharmaceutical Co.,Ltd.
MEDICAL & BIOLOGICAL LABORATORIES CO.
NANO MRNA Co., Ltd.
KISSEI PHARMACEUTICAL CO.,LTD.
Noile-Immune Biotech Inc.
DENKA SEIKEN Co.,Ltd.
Sanko Junyaku Co.,Ltd.
Perseus Proteomics Inc.
FunPep Company Limited